Ahmed El‐Mekabaty
Ahmed El‐Mekabaty publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Multicomponent Synthesis of Heterocycles.
- World rank
- #7,651,011 of 7,710,434 ranked researchers
- Rank in Egypt
- #36,153 of 36,277
- Works
- 66
- Citations
- 999
- Citations per work
- 15.1
What does Ahmed El‐Mekabaty research?
Ahmed El‐Mekabaty's work is mostly in Chemistry (85%), Biochemistry, Genetics and Molecular Biology (5%), Medicine (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences5887.2%
- Chemistry5685.1%
- Engineering12.1%
- Everything else35.1%
- Life Sciences34.6%
- Health Sciences23.1%
- Medicine23.1%
- 1Organic Chemistry83% of their works
- 2Molecular Biology5% of their works
- 3Pharmacology3% of their works
- 4Biomedical Engineering2% of their works
- 5Analytical Chemistry2% of their works
- 6Spectroscopy1% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Multicomponent Synthesis of Heterocycles
- Synthesis and Biological Evaluation
- Synthesis and Reactions of Organic Compounds
- Synthesis of heterocyclic compounds
- Quinazolinone synthesis and applications
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Ahmed El‐Mekabaty's research?
The keywords of their largest research topics: Synthesis, Heterocyclic Compounds, Medicinal Chemistry, Biological Evaluation, Drug Discovery, Heterocycles, Tubulin Inhibitors and Vascular Targeting Agents.
- Biological Activities
- Indirubin
- Annulation
- Imidazoles
- Antimicrobial Activity
- Green Chemistry
- Scaffold
- Antimicrobial
- Vascular Targeting Agents
- Heterocycles
- Biological Evaluation
- Heterocyclic Compounds
- Synthesis
- Medicinal Chemistry
- Drug Discovery
- Tubulin Inhibitors
- Anticancer
- Catalyst
- Triazines
- Multicomponent Reactions
- Quinoxaline
- Oxazolones
- Ketene Dithioacetal
- Quinazoline
- Phenothiazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Synthesis766 topics
- Heterocyclic Compounds562 topics
- Medicinal Chemistry562 topics
- Biological Evaluation493 topics
- Drug Discovery472 topics
- Heterocycles463 topics
- Tubulin Inhibitors401 topic
- Vascular Targeting Agents401 topic
- Anticancer393 topics
- Antimicrobial393 topics
- Catalyst282 topics
- Scaffold251 topic
- Triazines251 topic
- Green Chemistry221 topic
- Multicomponent Reactions221 topic
- Antimicrobial Activity161 topic
- Quinoxaline161 topic
- Imidazoles121 topic
- Oxazolones121 topic
- Annulation91 topic
- Ketene Dithioacetal91 topic
- Indirubin81 topic
- Quinazoline81 topic
- Biological Activities61 topic
- Phenothiazines61 topic
Where does Ahmed El‐Mekabaty work?
Ahmed El‐Mekabaty's main affiliation in the publication record is Mansoura University, Egypt.
How many publications and citations does Ahmed El‐Mekabaty have?
OpenAlex counts 66 works and 999 citations for Ahmed El‐Mekabaty, an h-index of 20, ranking #7,651,011 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ahmed El‐Mekabaty. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.